Written by BreastAugmentationInTurkey.org Editorial Team Published on 10 Sep 2026 Medically reviewed on 10 Sep 2026 Reviewed by Qualified plastic and reconstructive surgeon — to be confirmed before publication 3157 words

Poland Syndrome and Congenital Chest Differences: Why Standard Implant Studies May Not Apply

Poland syndrome breast augmentation evidence is limited by wide differences in muscle, ribs, soft tissue, breast development and reconstruction goals. This review explains why standard implant studies may not predict a congenital chest reconstruction.

Poland syndrome breast augmentation evidence is difficult to interpret because Poland syndrome is not simply a difference in breast volume. It may involve absence or hypoplasia of the pectoralis major muscle, changes in the pectoralis minor or other muscles, a narrower or deformed hemithorax, rib or cartilage differences, reduced subcutaneous tissue, and an underdeveloped or displaced breast and nipple–areola complex. The combination is different from one person to the next.

That anatomy changes the research question. A study of primary cosmetic augmentation in otherwise typical breast and chest anatomy may tell us something about an implant, pocket or complication, but it cannot automatically predict the result of reconstructing a congenital chest difference. Poland syndrome reconstruction is usually planned around the missing structures and the patient’s priorities. An implant may be part of that plan, but it is not a substitute for a pectoral muscle, a stable rib cage, missing skin or a displaced nipple.

Poland syndrome, also called Poland sequence or Poland anomaly in parts of the literature, is a congenital musculoskeletal condition. Its defining feature is usually unilateral absence or underdevelopment of the pectoralis major, most often involving the sternocostal portion. The pectoralis minor may also be affected. The anterior axillary fold can therefore be absent or less defined. Some people have associated hand differences such as symbrachydactyly or short digits; others have little or no limb involvement.

The label describes a spectrum rather than a single surgical diagnosis. One person may have a subtle pectoral defect and mild breast asymmetry. Another may have a markedly smaller hemithorax, absent breast tissue, a high or hypoplastic nipple–areola complex, rib aplasia, sternal rotation or additional muscle and limb differences. Bilateral features are reported but are uncommon. The same name therefore does not tell a surgeon the dimensions of the breast base, the thickness of the soft-tissue cover or whether an implant can be safely and predictably supported.

The cause is not settled. A vascular-disruption explanation involving the subclavian artery supply has been influential, but the proposed mechanism is not the same as a confirmed single-gene diagnosis. For reconstructive planning, the practical point is more important than the theory: the developmental difference may involve several layers of the chest, and those layers need to be assessed separately.

In routine augmentation, the pectoralis major may be used as part of the implant cover in a subpectoral or dual-plane pocket. In Poland syndrome, the muscle may be partially present, absent in its sternocostal portion, or absent more extensively. The muscle border may not match the expected textbook location. The pectoralis minor, serratus anterior, latissimus dorsi, deltoid or other regional muscles can also be hypoplastic in some patients.

This has two consequences. First, a planned “under-the-muscle” operation may not provide the same amount or distribution of muscle cover on the affected side as it would in a standard primary augmentation. The surgeon may need to describe exactly which muscle is present, where its edge lies and which part of the implant would remain covered by breast tissue, fascia or thin subcutaneous tissue. A pocket name alone is not enough.

Second, muscle-related movement cannot be inferred from a standard study in which the pectoralis is intact. If a muscle covers part of an implant, contraction can alter the breast contour. If the muscle is absent, that particular dynamic force may be reduced, but the implant may have less soft-tissue camouflage and less natural structural support. If a latissimus dorsi flap is transferred, it adds tissue and may be used to recreate an anterior axillary fold, but it is a reconstructive procedure with its own donor-site and functional considerations. The relevant question is how the person’s actual tissues will behave, not whether one label sounds familiar.

For athletes and people who rely heavily on shoulder or back function, donor-muscle decisions need particular care. A review of congenital breast anomalies notes that harvesting the ipsilateral latissimus dorsi for volume must be weighed against possible functional loss, especially in athletes. That is not a reason to reject a flap; it is a reason to include function, not only resting photographs, in the decision.

The visible breast difference may partly reflect the platform underneath it. Poland syndrome can include hypoplastic or absent ribs and costal cartilages, a narrower hemithorax, sternal asymmetry, pectus-type contour changes and, in severe cases, instability or altered respiratory mechanics. A rib or cartilage difference can change the slope, projection and width of the surface on which a breast reconstruction would sit.

An implant adds volume; it does not rebuild a missing rib or rotate a sternum into a symmetrical position. In a mild, stable chest wall, camouflage may be enough. In a severe or unstable defect, thoracic reconstruction may need to be considered before, with or instead of, breast or pectoral reconstruction. Consensus recommendations describe chest-wall correction as a functional or cosmetic decision according to the deformity, and note that a severe chest-wall anomaly is often addressed before breast and pectoral reconstruction to improve the final result.

That sequence is not a universal rule. Some combined approaches can reduce the number of procedures or make use of one incision, while other patients benefit from separating the bony, muscle and breast stages. The order depends on the size and stability of the defect, respiratory or cardiac findings, skeletal maturity, available tissue, and the intended contour. The 2024 surgical-algorithm paper likewise places multidisciplinary assessment and the thoracic component at the beginning of decision-making rather than treating the breast implant as the whole operation.

Breast hypoplasia or amastia on the affected side may occur with Poland syndrome, but the amount of breast tissue is not uniform. The nipple and areola can be smaller, less pigmented, higher than the opposite side or absent. The skin and subcutaneous layer may also be thin. In a less severe presentation, there may be enough native breast tissue for an implant to improve volume. In a more severe presentation, the missing breast mound and the missing subclavicular or axillary soft tissue are different reconstruction problems.

Thin coverage matters mechanically. An implant placed beneath a thin skin flap can be more visible or palpable, and a poorly supported pocket may be more vulnerable to displacement or contour irregularity. A larger device does not automatically solve a hollow under the collarbone or a deficient anterior axillary fold. A custom chest-wall prosthesis, fat grafting, a muscle or perforator flap, a tissue expander, an implant, or a staged combination may address different parts of the defect.

Nipple position also affects whether a reconstruction looks balanced. The congenital nipple may sit high because the breast and lower pole have not developed normally. Expanding the skin envelope can sometimes create space and lower the nipple before definitive breast reconstruction. If the nipple–areola complex is in an adequate position, expansion may not be needed for a modest reconstruction. These are examples of why the same implant volume can produce different relationships between nipple, fold and breast mound.

Breast development and body growth should be considered separately from the calendar age of a patient. Published congenital-reconstruction reviews describe definitive augmentation after the normal breast has matured, while expanders may be used earlier in selected circumstances. The correct timing is individualized and should account for skeletal and breast development, psychological readiness, future growth, and the possibility that later adjustment may be needed to maintain balance.

“Standard augmentation evidence” usually means evidence from primary cosmetic augmentation cohorts. For example, large clinical trials have examined how incision, anatomical pocket and implant device relate to capsular contracture, malposition and secondary procedures in primary augmentation. Those data are valuable for the population studied. They are not a direct trial of Poland syndrome, and they cannot isolate the effect of a congenital absence of muscle, rib asymmetry or deficient soft tissue.

The problem is not that every augmentation paper formally excludes every congenital chest difference. The more common limitation is that studies are not designed to stratify patients by Poland phenotype, hemithorax dimensions, muscle absence, nipple displacement, rib defects or previous reconstructive stages. A reported average therefore combines people whose tissue envelope and mechanical environment may be fundamentally different from the patient asking about congenital reconstruction.

Reconstructive studies have the opposite problem. A case series or systematic review of Poland syndrome can show which strategies have been used, but the patients often have different severities, ages, sex-related contour goals, prior operations and combinations of chest-wall and breast procedures. A flap-only case, a tissue-expander case and a single-implant case do not answer the same question. Outcomes may be reported as “good symmetry” without a validated measurement or a long, complete follow-up.

Evidence quality is further affected by rarity. A 2025 systematic review identified 77 eligible studies from 741 articles and extracted data from 209 patients; it found flap-based reconstruction in 60.3% of cases, tissue expanders in 22.5%, and no gold standard for all Poland syndrome deformities. These figures describe the published reconstruction literature, not the probability that a particular patient will need a flap or implant. The review’s central value is showing variation and the need for a decision framework, not producing a universal recipe.

A careful consultation starts with a bilateral comparison, not with an implant catalogue. The examination should map the pectoralis major and minor, the anterior axillary fold, the latissimus dorsi and other visible or functional muscle differences. It should record the breast base, fold level, nipple–areola position, skin quality, subcutaneous thickness, chest-wall contour and the size and shape of the opposite breast. Hand, shoulder, scapular and spinal findings may be relevant to the wider plan.

Imaging is selected for the question it needs to answer. The Poland syndrome consensus recommendations place comparative ultrasound of the pectoral region, breast tissue and subcutaneous tissues as a practical first-line tool. Chest radiography may help when rib or heart abnormalities are suspected. CT or MRI is not automatically required for every diagnosis, but can be useful in selected severe deformities or when a detailed view of ribs, sternum, muscle relationships or vascular anatomy is needed for surgical planning. The scan should clarify a decision; it should not be ordered as a ritual.

For a free-tissue reconstruction, vascular anatomy becomes especially important. For an implant-based plan, the key questions include the thickness and continuity of tissue cover, the location of the pocket boundaries and the stability of the fold. In either case, the assessment should also ask what outcome matters most: volume, upper-chest fullness, the axillary contour, nipple position, symmetry in clothing, symmetry without clothing, movement, or minimizing procedures. Those aims can point to different reconstructions.

There is no single “Poland syndrome implant.” In a mild deformity with a stable chest wall, adequate skin and some native breast tissue, an implant may provide useful volume, sometimes with fat grafting or soft-tissue adjustment. In another patient, a custom pectoral or chest-wall prosthesis may be more relevant than a breast implant because the principal deficit is above or beside the breast. A tissue expander may gradually create an envelope when the breast or nipple position is markedly deficient.

Autologous options include fat grafting, a latissimus dorsi flap, perforator flaps and other free-tissue transfers. Fat grafting can add camouflage without a permanent breast implant, although the available donor volume, the amount of asymmetry and the need for repeat sessions limit its use. A latissimus flap can supply soft tissue and recreate a fold, but it changes the donor site and may not be present or suitable. Perforator flaps can provide skin and fat without transferring the same muscle, but they require microsurgical expertise and appropriate vessels.

Hybrid and staged reconstruction are therefore common concepts rather than signs that a first plan has failed. A patient may first need chest-wall stabilization, then soft-tissue addition, then an expander or implant, followed by nipple–areola reconstruction or fat grafting. Other patients may reasonably choose a smaller, less invasive camouflage procedure. The 2021 algorithm study and the 2025 systematic review both emphasize individualization; neither supports promising one operation or one implant to everyone with the diagnosis.

In ordinary augmentation, subglandular, subpectoral, subfascial and dual-plane terms describe intended relationships between the implant and local tissues. In a congenital chest difference, the same word may conceal a different reality. A “dual-plane” pocket cannot provide normal pectoralis coverage where the muscle is absent. A prepectoral implant may avoid muscle animation but can be more visible if the soft-tissue envelope is thin. A muscle flap may create coverage, but it is no longer a routine primary augmentation.

The evidence from dual-plane surgery can still help explain tissue mechanics. Tebbetts’ foundational paper described combining upper muscle coverage with a more mobile lower-pole relationship in selected primary augmentation patients. That rationale is useful background, but the patient with Poland syndrome may have an incomplete or unusually shaped muscle, a different fold, a different breast base and a reconstruction goal rather than simple volume addition. The study can inform the vocabulary of the discussion; it cannot provide a congenital-specific outcome estimate.

A useful consultation should make the anatomy and uncertainty visible. Ask which parts of the pectoralis major and minor are present, whether the ribs or sternum change the breast platform, how much skin and subcutaneous cover exists, and whether the latissimus dorsi or another donor tissue is available. Ask which outcome the proposed procedure is designed to improve and which visible difference it is not expected to correct.

Also ask whether the plan is implant-only, tissue-based, hybrid or staged; why that sequence fits the defect; what imaging was used and what it showed; and how the opposite breast may change with time. If the proposed evidence comes from routine cosmetic augmentation, ask what is known specifically about congenital reconstruction and what is being inferred. A transparent answer may be less reassuring than a slogan, but it is more useful for consent.

For current procedural context, see the breast augmentation operation guide. For the plain-language congenital overview, read Breast Augmentation for Poland Syndrome and Congenital Chest Differences. The research review of implant pocket placement explains how subglandular, subpectoral and subfascial evidence is interpreted in primary cosmetic augmentation, while the planned reviews of congenital breast asymmetry and tuberous breasts address adjacent developmental differences. The breast augmentation all-inclusive package page is a logistical next step only; it is not evidence that a standard package or implant is suitable for Poland syndrome.

This is a narrative evidence review, not a systematic review or an individual surgical recommendation. Poland syndrome is rare and phenotypically heterogeneous. Much of the reconstructive literature consists of case reports, retrospective case series, institutional algorithms and reviews that pool different operations. Terminology for Poland syndrome, severity, muscle absence, breast aplasia, symmetry and success is not uniform. Follow-up is often incomplete, and the need for later revision or adjustment may be underreported.

The standard augmentation literature supplies useful information about implant mechanics, pocket terminology and complications in primary cosmetic cohorts, but it does not become congenital evidence simply because an implant was used. Conversely, a reconstructive case series can illustrate what is technically possible without establishing that the same option is safest or most durable for every patient. Current device labeling, physical examination and specialist assessment remain necessary for any individual decision.

The best-supported conclusion from Poland syndrome breast augmentation evidence is that anatomy must lead the plan. Muscle absence affects coverage and movement; rib-cage differences affect the platform; thin skin and subcutaneous tissue affect visibility and support; and breast or nipple underdevelopment affects the envelope and final relationships. These are not interchangeable versions of ordinary breast augmentation.

Implants can be useful in selected reconstructions, but they may be combined with fat grafting, muscle or perforator flaps, custom chest-wall prostheses, expansion or staged procedures. The evidence is too heterogeneous to promise one operation, one implant plane or exact symmetry. A responsible decision compares the person’s mapped anatomy and priorities with the limits of the available evidence, then records what improvement is realistic and what difference may remain.

What is Poland syndrome?

Poland syndrome is a congenital chest and musculoskeletal difference usually defined by absence or hypoplasia of part of the pectoralis major muscle. It may also involve the pectoralis minor, ribs, sternum, breast, nipple–areola complex, soft tissues and upper limb. The pattern and severity vary widely.

Can a breast implant correct Poland syndrome?

An implant may improve breast volume in a selected patient, but it cannot recreate a missing pectoral muscle or correct every rib, sternal, axillary or nipple difference. Some patients need soft-tissue, chest-wall, flap, fat-grafting, expander or staged reconstruction instead of implant-only surgery.

Why might ordinary breast augmentation research not apply to Poland syndrome?

Primary cosmetic augmentation studies usually do not stratify patients by absent pectoral muscle, rib asymmetry, thin soft-tissue cover, breast aplasia or displaced nipple. Their findings may inform implant mechanics, but they do not directly predict outcomes for a congenital reconstruction.

Is ultrasound, CT or MRI always needed before reconstruction?

No single scan is mandatory for every patient. Comparative ultrasound is commonly useful for mapping pectoral muscles, breast tissue and soft-tissue cover. Chest radiography, CT or MRI may be selected when rib, sternal, vascular or complex chest-wall anatomy needs clarification for diagnosis or surgical planning.

Will Poland syndrome reconstruction require more than one operation?

Not necessarily, but staged treatment is common when the chest wall, soft-tissue cover, breast mound and nipple–areola position need different corrections. The number and order of procedures depend on severity, development, available donor tissue, goals and the patient’s tolerance for additional surgery.

Is dual-plane placement suitable for every Poland syndrome patient?

No. A dual-plane label assumes a particular muscle–implant relationship, but Poland syndrome may leave the pectoralis incomplete or absent. The surgeon should explain the actual tissue coverage, the expected movement, the support of the fold and why another pocket, flap, fat graft or staged plan may be more appropriate.

Can reconstruction produce perfect symmetry?

Reconstruction can improve balance and contour, but perfect symmetry cannot be promised. The opposite breast continues to change with age, weight, pregnancy and hormonal factors, while the reconstructed side may have different tissue behavior and may need later adjustment.

Frequently asked questions

What is Poland syndrome? +
Poland syndrome is a congenital chest and musculoskeletal difference usually defined by absence or hypoplasia of part of the pectoralis major muscle. It may also involve the pectoralis minor, ribs, sternum, breast, nipple–areola complex, soft tissues and upper limb. The pattern and severity vary widely.
Can a breast implant correct Poland syndrome? +
An implant may improve breast volume in a selected patient, but it cannot recreate a missing pectoral muscle or correct every rib, sternal, axillary or nipple difference. Some patients need soft-tissue, chest-wall, flap, fat-grafting, expander or staged reconstruction instead of implant-only surgery.
Why might ordinary breast augmentation research not apply to Poland syndrome? +
Primary cosmetic augmentation studies usually do not stratify patients by absent pectoral muscle, rib asymmetry, thin soft-tissue cover, breast aplasia or displaced nipple. Their findings may inform implant mechanics, but they do not directly predict outcomes for a congenital reconstruction.
Is ultrasound, CT or MRI always needed before reconstruction? +
No single scan is mandatory for every patient. Comparative ultrasound is commonly useful for mapping pectoral muscles, breast tissue and soft-tissue cover. Chest radiography, CT or MRI may be selected when rib, sternal, vascular or complex chest-wall anatomy needs clarification for diagnosis or surgical planning.
Will Poland syndrome reconstruction require more than one operation? +
Not necessarily, but staged treatment is common when the chest wall, soft-tissue cover, breast mound and nipple–areola position need different corrections. The number and order of procedures depend on severity, development, available donor tissue, goals and the patient’s tolerance for additional surgery.
Is dual-plane placement suitable for every Poland syndrome patient? +
No. A dual-plane label assumes a particular muscle–implant relationship, but Poland syndrome may leave the pectoralis incomplete or absent. The surgeon should explain the actual tissue coverage, the expected movement, the support of the fold and why another pocket, flap, fat graft or staged plan may be more appropriate.
Can reconstruction produce perfect symmetry? +
Reconstruction can improve balance and contour, but perfect symmetry cannot be promised. The opposite breast continues to change with age, weight, pregnancy and hormonal factors, while the reconstructed side may have different tissue behavior and may need later adjustment.

Sources and references

The article distinguishes historical reports from later reviews. Links below are provided so readers can inspect the cited record directly.

  1. Perry D, Frame JD. The history and development of breast implants — Starting source S02/S33. Historical review used only for the distinction between implant development, primary augmentation and reconstructive uses; it does not provide Poland-syndrome outcome data.
  2. Tebbetts JB. Dual plane breast augmentation: optimizing implant-soft-tissue relationships in a wide range of breast types — Starting source S08. Foundational clinical series for dual-plane tissue relationships in selected primary cosmetic augmentation; it is not a congenital chest-wall study. PMID: 11373572. DOI: 10.1097/00006534-200104150-00027.
  3. Baldelli I, et al. Consensus based recommendations for diagnosis and medical management of Poland syndrome (sequence) — Orphanet Journal of Rare Diseases, 2020; 15:201. Consensus recommendations on the clinical spectrum, comparative ultrasound, selective CT/MRI, chest-wall assessment, reconstructive planning and follow-up. PMID: 32758259. DOI: 10.1186/s13023-020-01481-x.
  4. Caouette-Laberge L, Borsuk D. Congenital Anomalies of the Breast — Seminars in Plastic Surgery, 2013; 27(1):36–41. Describes the range of Poland chest, muscle, breast, nipple and soft-tissue findings and reconstructive options. PMID: 24872738. DOI: 10.1055/s-0033-1343995.
  5. Seyfer AE, Fox JP, Hamilton CG. Poland syndrome: evaluation and treatment of the chest wall in 63 patients — Plastic and Reconstructive Surgery, 2010; 126(3):902–911. Clinical series relating treatment selection to chest-wall anatomy and sex; not a randomized implant comparison. DOI: 10.1097/PRS.0b013e3181e60435.
  6. Schaverien MV, et al. Individualized implant-based reconstruction of Poland syndrome breast and soft tissue deformities — Retrospective series of 29 patients proposing an individualized algorithm; useful for illustrating heterogeneity, not for a universal complication estimate. PMID: 17992143.
  7. Kovacs T, et al. Development of a surgical treatment algorithm for breast reconstruction in Poland syndrome patients considering severity, sex, and BMI — 2021 retrospective institutional algorithm and literature review; the authors call for multicentre studies because of the small and heterogeneous evidence base. PMID: 34640539.
  8. Grande PK, et al. Reconstructive techniques for chest and breast deformities in Poland syndrome: an up-to-date systematic review — Journal of Plastic, Reconstructive & Aesthetic Surgery, 2025; 101:207–215. Systematic review of 77 eligible studies and 209 patients; reports varied flap, expander, implant and fat-grafting strategies and concludes there is no gold standard. PMID: 39818015. DOI: 10.1016/j.bjps.2024.12.008.
  9. Namnoum JD, et al. Primary breast augmentation clinical trial outcomes stratified by surgical incision, anatomical placement and implant device type — Primary cosmetic augmentation clinical-trial cohort used to explain what standard augmentation evidence can answer and what it cannot answer for congenital reconstruction. PMID: 23664574. DOI: 10.1016/j.bjps.2013.04.046.
  10. Surgical Algorithm of Poland Syndrome Based on Thorax, Breast, and Nipple-areola Complex Classification — Recent algorithmic cohort using thorax, breast and nipple–areola classification to structure reconstruction decisions; the cohort design does not establish a universal best procedure. PMID: 39583780.

Our medical review approach

BreastAugmentationInTurkey.org prepares its breast surgery information with a patient-first editorial process. We compare practical explanations with current regulator and specialist guidance, then check for the clinical details that can change with anatomy, implant choice and the individual plan. Our aim is to make the usual pathway easier to understand without presenting website information as an examination, diagnosis or personal treatment plan.

Clinical review Senior breast aesthetics consultants supporting BreastAugmentationInTurkey.org
Written by BreastAugmentationInTurkey.org Editorial Team

We revisit these pages when clinical guidance, implant information or the questions patients bring to consultation change. The goal is to stay clear about what is typical, what can vary from one breast to another, and which decisions should be made with the surgeon after an individual assessment.

Ready to take the next step?

Request your free consultation today. Our expert team will respond as soon as possible.